Baptist Health South Florida

Scholarly Commons @ Baptist Health South Florida
All Publications
2019

Snapshot of current carotid artery stenting practice and
accreditation in the USA
Barry Katzen
Baptist Hospital of Miami; Miami Cardiac & Vascular Institute, barryk@baptisthealth.net

Follow this and additional works at: https://scholarlycommons.baptisthealth.net/se-all-publications

Citation
BMJ Open Qual (2019) 8(4):e000671

This Article -- Open Access is brought to you for free and open access by Scholarly Commons @ Baptist Health
South Florida. It has been accepted for inclusion in All Publications by an authorized administrator of Scholarly
Commons @ Baptist Health South Florida. For more information, please contact Carrief@baptisthealth.net.

Open access

Original research

Snapshot of current carotid artery
stenting practice and accreditation in
the USA
David Sacks,1 Mary Beth Farrell   ,2 Barry T Katzen,3 Mary Lally,4
Jon S Matsumura,5 Nancy Merrill4
To cite: Sacks D, Farrell MB,
Katzen BT, et al. Snapshot of
current carotid artery stenting
practice and accreditation in
the USA. BMJ Open Quality
2019;8:e000671. doi:10.1136/
bmjoq-2019-000671
►► Additional material is
published online only. To view
please visit the journal online
(http://dx.doi.org/10.1136/
bmjoq-2019-000671).

Received 25 February 2019
Revised 16 September 2019
Accepted 21 September 2019

© Author(s) (or their
employer(s)) 2019. Re-use
permitted under CC BY-NC. No
commercial re-use. See rights
and permissions. Published by
BMJ.
1

Department of Radiology/
Interventional Radiology,
The Reading Hospital and
Medical Center, West Reading,
Pennsylvania, USA
2
Research, Intersocietal
Accreditation Commission,
Ellicott City, Maryland, USA
3
Miami Cardiac and Vascular
Center, Miami, Florida, USA
4
Intersocietal Accreditation
Commission, Ellicott City,
Maryland, USA
5
Department of Surgery, Division
of Vascular Surgery, University
of Wisconsin School of Medicine
and Public Health, Madison,
Wisconsin, USA
Correspondence to
Mary Beth Farrell;
farrell@intersocietal.org

Abstract

Objective The aim of this exploratory study was to
compare the performance of carotid artery stenting
(CAS) best practices between Intersocietal Accreditation
Commission (IAC) accredited facilities and non-accredited
facilities certified by the Centers for Medicare and
Medicaid Services (CMS).
Methods A random, anonymous survey was sent to
CMS and IAC accredited facilities querying facility routine
performance of 16 CAS procedure components found in
published guidelines and utilised during clinical trials.
Results There were 28 responses (response rate=17%).
Significant differences were found between the CMS
and the IAC facilities for four of 16 procedure measures:
determination of modified Rankin Scale score prior
to stenting (p=0.012, 95% CI 20% to 80%), accurate
measurement of per cent stenosis using electronic
callipers (p=0.005, 95% CI 24% to 84%), confirmation of
anticoagulation with activated clotting time greater than
250 s prior to crossing the lesion (p=0.03, 95% CI 7% to
69%), and comparison of facility outcomes to accepted
benchmarks for stroke and death (p=0.03, 95% CI 7% to
69%). Overall, IAC facilities performed all 16 procedures
more frequently (97%) than CMS facilities (66%) (p<0.001,
95% CI 24% to 36%).
Conclusions Although the sample size was small, the
results demonstrated IAC accredited facilities are more
likely to follow best practices, to use quantitative tools
to select appropriate patients, and quantitively measure
patient-centred clinical outcomes compared with CMS
certified facilities. The findings raise the question as to the
value of CMS certification versus IAC accreditation as a
requirement for reimbursement.

In 2005, the Centers for Medicare and
Medicaid Services (CMS) instituted coverage
for carotid artery stenting (CAS) procedures
for high-risk surgical patients. At that time,
there were no recognised multispecialty
organisations evaluating CAS procedures.
Therefore, CMS established a certification
mechanism for evaluating CAS facilities
as a condition of reimbursement for CAS
procedures.1
For initial CMS certification, a facility must
meet structural criteria of either having
participated in a clinical trial leading to
Food and Drug Administration approval of

a stenting device or self-attest that it meets
minimum standards for equipment, device
inventory, staffing and infrastructure. The
certification duration is 2 years. To be recertified, facilities submit a log of CAS procedures
performed. The log includes patient selection information related to high surgical risk
criteria, symptomatic status, modified Rankin
Scale (mRS) score if the patient had a history
of stroke, per cent diameter stenosis of the
artery, and whether there were complications
during the hospital stay.
Since the establishment of CMS’ certification requirements, stakeholders from professional societies gathered to create standards
and develop the Intersocietal Accreditation
Commission (IAC) Carotid Artery Stenting
accreditation programme based on published
guidelines and expert opinion.2 The IAC Standards for Carotid Stenting Accreditation define
minimum levels of quality based on both
processes and outcomes related to the performance of CAS procedures.3 The IAC began
accrediting CAS facilities in 2011.
The IAC CAS accreditation process requires
submission of case logs that include clinical
outcomes. IAC staff select a random sample
of cases for detailed analysis of the relevant
medical records and procedure images.
Trained IAC staff also perform a mandatory
site visit. The quality of facility operation is
determined based on compliance with the
Standards. Expert physicians on the IAC CAS
Board review the submitted materials and site
visit findings to make accreditation decisions.
Major deficiencies such as failure to perform
neurological assessments must be addressed
before accreditation is awarded.
Whether there are differences in adherence
to published guidelines and best practices
between IAC accredited and CMS non-accredited CAS facilities is not known.2 Therefore, this exploratory survey was designed to
assess and compare the performance of CAS
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from the 1366 CMS certified facilities. The selection was
made using a random number generator without replacement. A paper survey was mailed to the selected CMS
facilities on at least three separate occasions in January,
February and March 2017.

best practices between IAC accredited and non-accredited facilities.
Methods
An anonymous survey was conducted in 2017 to compare
CAS practices between IAC accredited and non-accredited
facilities (online supplementary file A). Non-IAC accredited facilities were randomly selected from a pool of CMS
certified facilities. The IAC and CMS facilities selected
were mutually exclusive. The same survey was used for
both groups, but different survey media was utilised due
to differences in the contact information available.

Intersocietal Accreditation Commission
The same survey was sent electronically to the technical
directors of all accredited IAC facilities twice in August
2017; 2 weeks apart.

Centers for Medicare and Medicaid Services
A list of CMS certified facilities was obtained from the
CMS.gov website.4 At the time the file was retrieved, there
were 1366 certified facilities. The data available included
facility name, address, provider number, and the effective
date of certification.
The facility name and address were verified on the
internet for a consecutive sample of 100 facilities to test the
integrity of the list. Out of those 100 facilities, one facility
was no longer in business. Thus, it was assumed that the
information was incorrect for 1% of the list. Therefore, at
least a 10% random sample plus 1% (n=152) was selected

Survey
The survey consisted of a combination of dichotomous,
checkbox, multiple-choice and free text questions. There
were two categories of questions: demographic items
(five) and procedure metrics (16). Respondents were
asked to indicate if they routinely performed 16 procedure components (table 1). These components were
selected from protocols found in the literature, required
for CMS certification, utilised during CAS clinical trials,
and included in documentation and procedure quality
variables assessed in the IAC accreditation process.2 5 6
For categorical variables, the frequency and percentage
were calculated. For continuous variables, the total,
median and range were reported. A summed score and

Table 1 Performance of self-reported best practice procedure components

Best practice

CMS (%) IAC (%)
(n=22)
(n=6)

Fisher’s exact
Overall
comparing CMS
(%) (n=28) versus IAC p value

mRS pre-stent
NIHSS pre-stent

36
77

100
100

50
82

DSA including head and neck pre-stent

77

66

Electronic calliper determination of per cent
stenosis

32

Measure per cent stenosis using NASCET
criteria

95% CI of the
frequencies
Lower
(%)

Upper
(%)

0.01
0.55

20
−18

80
43

75

0.62

−21

49

100

46

0.005

24

84

68

100

75

0.29

−10

53

Embolic protection device use

91

100

93

1.00

−31

28

DSA including head and neck post-stent

73

83

75

1.00

−32

36

Treated with antiplatelet dual regimen

82

100

86

0.55

−22

39

ACT >250 s

55

100

64

 0.05

2

65

NIHSS 24 hours post-stent

77

100

82

0.55

−18

43

~30-day post-stent neurological assessment

82

100

86

0.55

−22

39

~30-day post-stent follow-up mRS

64

100

71

0.14

−6

57

~30-day post-stent follow-up NIHSS

64

100

71

0.14

−6

57

~30-day post-stent outcomes stroke and death 73

100

79

0.29

−14

48

~30-day non-invasive study

59

100

68

0.14

−2

59

Benchmark for stroke and death
Overall

50
66

100
97

61
73

0.03
<0.001

7
24

69
36

ACT, activated clotting time; CMS, Centers for Medicare and Medicaid Service; DSA, digital subtracted angiography; IAC, Intersocietal
Accreditation Commission; mRS, Modified Rankin Scale; NASCET, North American Symptomatic Carotid Endarterectomy Trial; NIHSS,
National Institute of Health Stroke Scale.
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percentage by metric and group were calculated. Comparisons between groups were made using Fisher’s exact test.
The significance level was set at 0.05, with the 95% CI
reported. Statistical analyses were performed using IBM
SPSS V.22.0.
As the list of CMS certified facilities included facilities
that potentially might have participated in the Carotid
Revascularization and Medical Management for Asymptomatic Carotid Stenosis Study Trial (CREST-2), a further
subanalysis was performed to compare the best practices of
CMS facilities that indicated participation in the CREST-2
and those that did not participate in CREST-2.7 This evaluation was done for exploratory purpose, and as there
was only a small number of facilities, a statistical analysis
was not performed. The frequency and percentage were
reported for each group and overall.
A typical response rate for email surveys is 2%–5%, for
generic postal surveys 7.5%, and for personalised postal
surveys 10.5%.8 Therefore, a minimum response rate of
10.5% was established for all surveys due to the mixed
media survey methods used.
The research protocol was reviewed by an institutional
review board and deemed to be exempt as the survey was
voluntary, anonymous, and did not involve the collection
of protected health information. An explanation was
provided at the beginning of the survey, and all respondents indicated their willingness to participate. As an
incentive to participate in the survey, a $100 charitable
donation was offered.
Patient and public involvement statement
Patients were not involved in the design or data collection
for this study.
Results
Paper surveys were sent to 152 randomly selected CMS
facilities, and electronic surveys of the same questions
were sent to 6 IAC facilities. There were 28 responses
(overall response rate=17%) to the survey (CMS=22
(15%) and IAC=6 (100%)).
Demographic data
Most of the responding facilities were medium-sized
with between 100 and 500 beds (n=23, 82%). The rest
of the facilities were almost equally distributed between
small facilities, less than 100 beds (n=2, 7%), and large
facilities, more than 500 beds (n=3, 11%). The median
number of procedures performed per facility annually
was 13 (range 3–90).
The median number of physicians performing CAS per
facility was 2 (range 1–8). Most facilities had a combination of physician specialties performing procedures. Of
the total reported, vascular surgeons (n=18, 36%) and
interventional cardiologists (n=13, 26%) were the most
frequent followed by interventional radiologists (n=10,
20%). Interventional neurologists (n=5, 10%) and neurosurgeons (n=4, 8%) represented the smallest numbers.
Sacks D, et al. BMJ Open Quality 2019;8:e000671. doi:10.1136/bmjoq-2019-000671

Most facilities participated in at least one registry or
clinical study (n=20, 71%). The American College of
Cardiology’s National Cardiovascular Data Registry-Peripheral Vascular Intervention (NCDR-PVI™) was the
most common registry (n=10, 36%) followed by the
CREST-2 registry (n=8, 29%). Facilities also participated in the following registries: the Society for Vascular
Surgery Vascular Quality Initiative (SVS-VQI) (n=6,
21%); the Safety and Efficacy Study for Reverse Flow
Used During Carotid Artery Stenting Procedure (ROADSTER) (n=2, 7%); and the Carotid Stent Clinical Study
for the treatment of carotid artery stenosis in patients at
increased risk for adverse events from carotid endarterectomy (SCAFFOLD) (n=3, 11%). Almost one-third of
responding facilities (n=8, 29%) did not participate in
registries. We found that CMS certified facilities were less
likely to engage in registries (64%) compared with IAC
facilities (100%), although the difference was not significant (p=0.14, 95% CI −6% to 57%).
Procedure metrics overall
Utilisation of an embolic protection device during the
stenting procedure was most frequently utilised (n=26,
93%) by the facilities. Thirty-day post-stenting neurological assessment (n=24, 86%), 30-day mRS score (n=20,
71%), and 30-day National Institute of Health Stroke
Scale (NIHSS) score (n=20, 71%) were also frequently
performed (table 1).
The least performed metric was the determination of
the degree of stenosis from the catheter angiogram using
electronic callipers (n=13, 46%). Other less frequently
performed metrics included mRS assessment prior to
stenting (n=14, 50%), facility outcomes benchmarking
for stroke and death (n=17, 61%), and non-invasive diagnostic imaging 30-days post-stent (n=19, 68%).
Overall, the average performance of the 16 procedure
metrics by the respondent facilities was 73%.
Procedure metric comparison by accreditation status
Significant differences were found between the CMS and
IAC facilities for four of the 16 procedure measures with
the IAC accredited facilities reporting more frequent
metric performance (table 1): determination of mRS
score prior to stenting (p=0.012, 95% CI 20% to 80%),
accurate measurement of per cent stenosis using electronic callipers (p=0.005, 95% CI 24% to 84%), confirmation of anticoagulation with activated clotting time
greater than 250 s prior to crossing the lesion (p=0.03,
95% CI 7% to 69%), and comparison of facility outcomes
to accepted benchmarks for stroke and death (p=0.03,
95% CI 7% to 69%).
Overall, IAC facilities performed all 16 metrics more
frequently (97%) than CMS facilities (66%) (p<0.001,
95% CI 24% to 36%).
The exploratory analysis evaluating CMS facilities
participating in the CREST-2 trial demonstrated that
those facilities (n=3) utilised almost all of the 16 best
practices when performing CAS with the exception of
3
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Table 2 Performance of self-reported best practice procedure components for CMS facilities (n=22)

Best practice

Non-CREST participants (%)
(n=19)

CREST participants
(%)
(n=3)

mRS pre-stent
NIHSS pre-stent

32
74

67
100

DSA including head and neck pre-stent

74

100

Electronic calliper determination of per cent stenosis

21

100

Measure per cent stenosis using NASCET criteria

63

100

Embolic protection device use

90

100

DSA including head and neck post-stent

68

100

Treated with antiplatelet dual regimen

79

100

ACT >250 s

47

100

NIHSS 24 hours post-stent

74

100

~30-day post-stent neurological assessment

79

100

~30-day post-stent follow-up mRS

58

100

~30-day post-stent follow-up NIHSS

58

100

~30-day post-stent outcomes stroke and death

68

100

~30-day non-invasive study

58

67

Benchmark for stroke and death
Overall

42
62

100
100

ACT, activated clotting time; CMS, Centers for Medicare and Medicaid Services; CREST, Carotid Revascularisation and Medical Management
for Asymptomatic Carotid Stenosis Study Trial; DSA, digital subtracted angiography; mRS, Modified Rankin Scale; NASCET, North American
Symptomatic Carotid Endarterectomy Trial; NIHSS, National Institute of Health Stroke Scale.

two practices (table 2): mRS pre-stent (67%) and 30-day
non-invasive imaging (67%). The omitted best practices
for the two variables represented different facilities.
Discussion
The use of CAS to reduce the risk of stroke and death
among patients 70 years or older with carotid artery disease
increased significantly from 2007 to 2014.9 The American
College of Cardiology and American Heart Association
guidelines recommend outcomes for periprocedural
stroke or mortality of <6% for symptomatic patients and
<3% for asymptomatic patients.10 However, favourable
results of CAS are highly dependent on the incidence of
periprocedural complications.11 Periprocedural events
are contingent on an operator’s skill and experience,
patient selection and procedure technique.
Multiple studies have documented the relationship
between patient outcomes and competence of the operating team and facility.12–14 There is a steep learning
curve for CAS with an inverse relationship between operator or facility volume and event rates. Operator and
facility volumes were the most significant determinant
of periprocedural outcomes.14 Recommendations for
training criteria and volume requirements vary between
professional societies.15 The experience and training of
physicians performing routine CAS are not captured in
the CMS data.13
4

CAS is associated with potential serious complications,
and patients should not be subjected to that risk if they
are not likely to benefit from the procedure.16 In general,
symptomatic patients that have >50% carotid stenosis and
asymptomatic patients with >80% carotid stenosis are
suitable candidates for CAS.5 6 There is ongoing controversy about indications and ongoing research. However,
outside of approved clinical trials, CMS limits reimbursement to symptomatic, high surgical risk patients with
stenosis >70%.1
The intent of the CMS certification programme is to
confirm that facilities receiving payment for CAS procedures are qualified to perform CAS and achieve acceptable clinical outcomes.7 Indeed, the CMS payment
memorandum states “facilities and providers that
routinely and repeatedly perform this procedure and
follow patients for long periods of aftercare have a greater
chance of successful outcomes.”1 However, the current
structural focus of the CMS self-certification process does
not require facilities to measure outcomes.1 A study by
Epstein et al found that risk-standardised CAS outcomes
fluctuate markedly across the USA; implying that facilities with both high and low adverse events are certified
by CMS.17
The IAC Standards are based on published guidelines
and expert consensus.3 They are designed to create best
practices with the expectation that these practices will
maximise CAS procedure quality and clinical outcomes.
Sacks D, et al. BMJ Open Quality 2019;8:e000671. doi:10.1136/bmjoq-2019-000671
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The Standards also provide metrics that can be used
to measure clinical outcomes accurately. The results
of this study show that IAC facilities are significantly
more compliant with recommended best practices than
non-IAC accredited facilities. It is reasonable to assume
that this is likely to lead to better clinical outcomes and
appropriately selected patients.
One of those best practices is electronic calliper
measurement of per cent stenosis. In fact, the CMS
memorandum for CAS states that if the degree of stenosis
is less than 70% by angiography at the start of the procedure, CAS should not proceed. However, the memorandum does not suggest a method of ascertaining the
degree of stenosis. Per cent stenosis may be determined
by visual estimate or measured with electronic callipers.
Determination of stenosis by electronic calliper has superior accuracy. Visual estimate of per cent stenosis has
been demonstrated to misclassify and overestimate the
degree of stenosis, especially in the presence of 50%–80%
stenosis.18 Overestimation of stenosis may lead to unnecessary interventions. In this study, only 32% of CMS certified facilities indicated they used electronic callipers to
determine per cent stenosis compared with 100% of IAC
accredited facilities.
Assessment of peri-CAS and post-CAS stroke is necessary to determine clinical outcome for a procedure
performed to prevent stroke. This requires both a
follow-up visit and an objective measure of neurological
deficit, such as the NIHSS. While major neurological
deficits will be obvious, minor deficits may be overlooked
but may still have a large impact on quality of life.19 This
evaluation is critical in comparing outcomes to national
benchmarks.
The findings from this study suggest the utility of
accreditation in promoting adherence to best practices
of patient selection and assessment of patient outcomes.
The comparison of results from CMS facilities to IAC
accredited facilities implies that CMS facilities may not
necessarily comply with process measures such as the
metrics assessed in this study despite CMS requirements.
The results indicate it is helpful to have an external
entity that audits and provides oversight to ensure best
practices such as appropriate patient selection, assessment of clinical outcomes, and comparison of clinical
outcomes to nationally accepted benchmarks of patient
benefit.
Further, this exploratory examination of a limited
number of CMS facilities that also participated in the
CREST-2 trial, although notable but not statistically significant, showed they were for the most part very similar to
the IAC accredited facilities. This likewise suggests that
an external mechanism of accountability, whether in the
form of accreditation or participation in a clinical trial,
contributes to improving adherence to best practices
to ensure quality patient care. Accreditation potentially
allows the quality present during a clinical trial to be
generalised outside of the clinical trial environment. This
is an area for further investigation.
Sacks D, et al. BMJ Open Quality 2019;8:e000671. doi:10.1136/bmjoq-2019-000671

Limitations
This study is limited by the absence of actual outcomes
determination and reporting by non-IAC accredited facilities. Although outcomes data might be available from
clinical registries, many of the CMS facilities indicated
they did not participate in registries. The study is further
limited in that the selected best practices were also not
verified directly but self-reported with likely response
bias. However, compliance with the selected best practices by IAC facilities was confirmed at the time of the
accreditation process site visit. It was assumed that the
selected procedure best practices were a determinant of
better patient clinical outcomes. It was also assumed that
the IAC accreditation process was an accurate assessment
of facility quality and best practice adherence.
The study is further limited by the small number of
facilities that have sought specialty CAS accreditation by
the IAC or the other accreditation organisation; Accreditation for Cardiovascular Excellence (ACE). ACE’s
accreditation requirements are relatively similar to the
IAC’s accreditation programme.20 The response rate
for the survey was low but in line with response rates of
other internet surveys.8 Finally, inherent selection bias is
possible in that the type of individual likely to respond
to a survey might also be more likely to adhere to performance guidelines.
Conclusions
Our evaluation of guideline adherence and best practices
among facilities performing CAS procedures found that
despite the small number of facilities, IAC accredited
facilities are more likely to follow best practices compared
with CMS certified facilities. The most relevant quality
measures are appropriate patient selection and reduced
risk of postprocedure stroke or death. IAC accredited
facilities are more likely than CMS accredited facilities to
use quantitative tools to select appropriate patients and
quantitatively measure patient-centred clinical outcomes.
The results raise the question as to the value of CMS certification as a requirement for reimbursement.
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